RTSNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Retension Pharmaceuticals, Inc.
$16.33+2.26 (+16.06%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Retension Pharmaceuticals has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Retension Pharmaceuticals filed with the SEC
CURRENT REPORT
Event dated Oct 9, 2026, from SEC EDGAR